These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 18428420

  • 21. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P.
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [Abstract] [Full Text] [Related]

  • 22. Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility.
    Akashi M, Koeffler HP.
    Clin Obstet Gynecol; 1998 Mar; 41(1):172-99. PubMed ID: 9504235
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
    Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S.
    Gastroenterology; 2006 Jan; 130(1):73-9. PubMed ID: 16401470
    [Abstract] [Full Text] [Related]

  • 24. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T, Soussi T.
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [Abstract] [Full Text] [Related]

  • 25. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
    Paunu N, Syrjäkoski K, Sankila R, Simola KO, Helén P, Niemelä M, Matikainen M, Isola J, Haapasalo H.
    J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
    [Abstract] [Full Text] [Related]

  • 26. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J, Schmidt G, Hofmann W, Schubert S, Schieck M, Auber B, Ripperger T, Hackmann K, Sturm M, Prokisch H, Hille-Betz U, Mark D, Illig T, Schlegelberger B, Steinemann D.
    Breast Cancer Res; 2018 Aug 07; 20(1):87. PubMed ID: 30086788
    [Abstract] [Full Text] [Related]

  • 27. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D.
    Cancer Res; 1994 Mar 01; 54(5):1298-304. PubMed ID: 8118819
    [Abstract] [Full Text] [Related]

  • 28. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 01; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 29. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
    Soussi T, Leblanc T, Baruchel A, Schaison G.
    Nouv Rev Fr Hematol (1978); 1993 Feb 01; 35(1):33-6. PubMed ID: 8511038
    [Abstract] [Full Text] [Related]

  • 30. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J, Sakurai N, Iwamoto S, Nishioka J, Nakatani K, Komada Y, Mizutani S, Takagi M.
    Mol Carcinog; 2013 Oct 01; 52(10):770-6. PubMed ID: 22495821
    [Abstract] [Full Text] [Related]

  • 31. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH.
    Nature; 2013 Oct 01; 348(6303):747-9. PubMed ID: 2259385
    [Abstract] [Full Text] [Related]

  • 32. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
    Kouidou S, Malousi A, Maglaveras N.
    Mol Carcinog; 2009 Oct 01; 48(10):895-902. PubMed ID: 19367569
    [Abstract] [Full Text] [Related]

  • 33. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
    Malmer B, Grönberg H, Andersson U, Jonsson BA, Henriksson R.
    Acta Oncol; 2001 Oct 01; 40(5):633-7. PubMed ID: 11669337
    [Abstract] [Full Text] [Related]

  • 34. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
    Macedo GS, Araujo Vieira I, Brandalize AP, Giacomazzi J, Inez Palmero E, Volc S, Rodrigues Paixão-Côrtes V, Caleffi M, Silva Alves M, Achatz MI, Hainaut P, Ashton-Prolla P.
    Cancer Genet; 2016 Mar 01; 209(3):97-106. PubMed ID: 26823150
    [Abstract] [Full Text] [Related]

  • 35. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y, Tsunematsu Y, Watanabe S, Tsukamoto T, Kawa-ha K, Hirata Y, Mizoguchi H, Sugimura T, Terada M, Yokota J.
    J Natl Cancer Inst; 1992 May 06; 84(9):703-7. PubMed ID: 1569604
    [Abstract] [Full Text] [Related]

  • 36. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
    Menko FH, Nooy MA, Vasen HF.
    Ned Tijdschr Geneeskd; 1996 Jun 29; 140(26):1347-50. PubMed ID: 8710022
    [No Abstract] [Full Text] [Related]

  • 37. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH.
    Proc Natl Acad Sci U S A; 1992 Jul 15; 89(14):6413-7. PubMed ID: 1631137
    [Abstract] [Full Text] [Related]

  • 38. Li-Fraumeni syndrome and the role of the pediatric nurse practitioner.
    Parsons M.
    Clin J Oncol Nurs; 2011 Feb 15; 15(1):79-87. PubMed ID: 21278043
    [Abstract] [Full Text] [Related]

  • 39. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
    Fiszer-Maliszewska L, Czernik J, Sawicz-Birkowska K, Perek D, Kozera M, Wojciechowska B, Kazanowska B, Hudziec P, Kilar E.
    Arch Immunol Ther Exp (Warsz); 2000 Feb 15; 48(4):309-15. PubMed ID: 11059649
    [Abstract] [Full Text] [Related]

  • 40. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S, Gharbi O, Zrig M, Gribaa M, Njim L, Zakhama A, Abid A, Frébourg T, Ahmed SB.
    Ann Biol Clin (Paris); 2010 Feb 15; 68(3):346-50. PubMed ID: 20478780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.